Related Experiment Video
Updated: May 24, 2026

In Vitro Resident Memory CD8 T Cell Differentiation Using Epithelial Organoid-T Cell Co-culture System
Published on: February 3, 2026
Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity
Lukas Baitsch1, Amandine Legat, Leticia Barba
1Clinical Tumor Biology and Immunotherapy Unit, Ludwig Center, University of Lausanne, Lausanne, Switzerland.
Abstract:
Inhibitory receptors mediate CD8 T-cell hyporesponsiveness against cancer and infectious diseases. PD-1 and CTLA-4 have been extensively studied, and blocking antibodies have already shown clinical benefit for cancer patients. Only little is known on extended co-expression of inhibitory receptors and their ligands. Here we analyzed the expression of eight inhibitory receptors by tumor-antigen specific CD8 T-cells. We found that the majority of effector T-cells simultaneously expressed four or more of the inhibitory receptors BTLA, TIM-3, LAG-3, KRLG-1, 2B4, CD160, PD-1 and CTLA-4. There were major differences depending on antigen-specificity, differentiation and anatomical localization of T-cells. On the other hand, naive T-cells were only single or double positive for BTLA and TIM-3. Extended co-expression is likely relevant for effector T-cells, as we found expression of multiple ligands in metastatic lesions of melanoma patients. Together, our data suggest that naive T-cells are primarily regulated by BTLA and TIM-3, whereas effector cells interact via larger numbers of inhibitory receptors. Blocking multiple inhibitory receptors simultaneously or sequentially may improve T-cell based therapies, but further studies are necessary to clarify the role of each receptor-ligand pair.
Insights
Naive T-cells are regulated by BTLA and TIM-3, while effector T-cells express multiple inhibitory receptors. Targeting these receptors may enhance T-cell therapies for cancer and infectious diseases.
Area of Science:
- Immunology
- Cancer Biology
- T-cell Biology
Background:
- Inhibitory receptors regulate CD8 T-cell responses in cancer and infections.
- Programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) are well-studied, with blocking antibodies showing clinical efficacy.
- Limited knowledge exists regarding the co-expression patterns of multiple inhibitory receptors and their ligands.
Purpose of the Study:
- To analyze the expression of eight inhibitory receptors on tumor-antigen specific CD8 T-cells.
- To investigate differences in receptor expression based on antigen-specificity, differentiation, and anatomical location.
- To explore the relevance of co-expressed inhibitory receptors and their ligands in cancer.
Main Methods:
- Flow cytometry analysis of eight inhibitory receptors (BTLA, TIM-3, LAG-3, KRLG-1, 2B4, CD160, PD-1, CTLA-4) on CD8 T-cells.
- Analysis of T-cell expression patterns in relation to antigen-specificity, differentiation status, and anatomical site.
- Detection of inhibitory receptor ligands in metastatic melanoma lesions.
Main Results:
- The majority of effector CD8 T-cells expressed four or more inhibitory receptors simultaneously.
- Naive T-cells predominantly expressed only BTLA and TIM-3.
- Significant variations in receptor co-expression were observed based on antigen-specificity, differentiation, and anatomical localization.
- Multiple inhibitory receptor ligands were detected in metastatic melanoma lesions, suggesting functional relevance.
Conclusions:
- Naive T-cells are primarily regulated by BTLA and TIM-3.
- Effector CD8 T-cells engage a broader array of inhibitory receptors.
- Simultaneous or sequential blockade of multiple inhibitory receptors could potentially enhance T-cell based immunotherapies.
- Further research is needed to elucidate the specific roles of individual receptor-ligand interactions.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

